Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

70.68 10.76 −13.21%
Market cap
$10.9B
P/E
19.5×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 5 Nov
P/E ratio

+8 more quarters

21.94 19.81 19.90 18.09
P/S ratio
4.02 3.76 3.39 3.20
P/FCF ratio
20.75 19.75 14.50 13.45
P/Operating CF
47.49 57.63 50.88 37.88
P/B ratio
2.58 2.46 2.24 2.09
EV/Sales
4.12 3.84 3.48 3.28
EV/EBITDA
15.47 14.27 11.72 11.06
EV/FCF
21.28 20.14 14.86 13.81
Current Ratio
4.26 4.56 4.62 4.30
Net Debt/EBITDA
(2.27) (2.86) (2.36) —
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
4.56% 5.05% 5.02% 5.53%
Free Cash Flow Yield
4.82% 5.06% 6.90% 7.43%
Free Cash Flow per Share
1.50 1.20 1.31 1.68
Book value per Share
33.82 34.96 35.31 35.75
Free Cash Flow
202.31 162.75 176.57 224.84
EV/EBIT
25.24 22.31 17.10 15.17
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026